Monaco Asset Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-253,185
| Closed | -$314K | – | 66 |
|
|
2024
Q2 | $314K | Sell |
253,185
-81,557
| -24% | -$101K | 0.05% | 52 |
|
|
2024
Q1 | $633K | Sell |
334,742
-7,500
| -2% | -$14.2K | 0.19% | 42 |
|
|
2023
Q4 | $904K | Sell |
342,242
-17,497
| -5% | -$46.2K | 0.27% | 50 |
|
|
2023
Q3 | $827K | Sell |
359,739
-10,668
| -3% | -$24.5K | 0.25% | 40 |
|
|
2023
Q2 | $1.35M | Sell |
370,407
-95,938
| -21% | -$350K | 0.38% | 35 |
|
|
2023
Q1 | $1.66M | Sell |
466,345
-30,832
| -6% | -$110K | 0.51% | 31 |
|
|
2022
Q4 | $1.42M | Buy |
497,177
+38,326
| +8% | +$109K | 0.43% | 39 |
|
|
2022
Q3 | $1.02M | Buy |
458,851
+15,000
| +3% | +$33.4K | 0.39% | 43 |
|
|
2022
Q2 | $1.11M | Buy |
443,851
+398,851
| +886% | +$993K | 0.48% | 36 |
|
|
2022
Q1 | $220K | Buy |
+45,000
| New | +$220K | 0.09% | 40 |
|